中文

Hong Kong Stocks · Free Data Page

MEDBOT-B 02252

MEDBOT-B: FY2025 revenue CN¥551.1M (+114.20% YoY); net income -CN¥249.7M; 4 alerts, 3 watch items out of 17 risk checks; no TTM dividend.
Close PriceHK$21.18Day 0.00%Market CapHK$21.84BP/E—Negative earningsP/B48.04xROE (FY2025)-72.5%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for MEDBOT-B?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2019–2025

Financial statements are reported in CNY, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Net income was negative in FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (CNY B)0.000.020.100.260.55
YoY—904.8%384.2%146.0%114.2%
Net Income (CNY B)-0.58-1.14-1.01-0.64-0.25
Operating Cash Flow (CNY B)-0.54-0.90-0.57-0.30-0.02
ROE-30.4%-59.8%-104.5%-161.1%-72.5%
Gross Margin42.7%30.4%14.0%33.5%48.4%
Net Margin-27112.6%-5276.1%-967.7%-249.7%-45.3%
Debt-to-Assets14.4%27.1%64.9%79.9%70.0%
Show all 7 fiscal years
Fiscal Year2019202020212022202320242025
Revenue (CNY B)—0.000.000.020.100.260.55
YoY———904.8%384.2%146.0%114.2%
Net Income (CNY B)-0.07-0.21-0.58-1.14-1.01-0.64-0.25
Operating Cash Flow (CNY B)-0.05-0.10-0.54-0.90-0.57-0.30-0.02
ROE-264.3%-28.4%-30.4%-59.8%-104.5%-161.1%-72.5%
Gross Margin——42.7%30.4%14.0%33.5%48.4%
Net Margin——-27112.6%-5276.1%-967.7%-249.7%-45.3%
Debt-to-Assets66.3%15.4%14.4%27.1%64.9%79.9%70.0%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

4Alert 3Watch 8Pass 2N/A

Items Flagged for Review

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Net LossesGoing Concern

    FY2025 (2025-12-31) CN¥-0.25B, FY2024 (2024-12-31) CN¥-0.64B

    FY2025 (ended 2025-12-31)

  • Alert

    Delayed Financial ResultsMaterial Events

  • Alert

    Trading SuspensionMaterial Events

  • Watch

    Receivables DaysFinancial Quality

    174.7 days, prior FY 131.7 days(+33%)

    FY2025 (ended 2025-12-31) · What is this?

  • Watch

    Debt-to-Assets RatioSolvency

    70.0%

    FY2025 (ended 2025-12-31) · What is this?

  • Watch

    High Cash & High DebtSolvency

    cash 47.7% of assets, total debt 29.2% of assets

    FY2025 (ended 2025-12-31)

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.